Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| ACIUAC Immune SA | $291.07M | — | CHF 3.57M | -86.9% | -CHF 70.45M | CHF 26.8M | CHF 4.54M | AI pending |
| GBFHGBank Financial Holdings Inc. | $291.35M | 15.7× | $76.02M | +21.9% | $20.93M | $141.33M | $5.38M | AI pending |
| ACGCACP Holdings Acquisition Corp. | $291.59M | — | — | — | — | $746.22K | — | AI pending |
| MKTWMarketwise, Inc. | $291.67M | 21.0× | $328.12M | -19.7% | $5.62M | $32.91M | $5.54M | AI pending |
| MTRXMatrix Service Co | $291.75M | — | $873.63M | +13.6% | -$2.58M | $222.97M | $19.46M | AI pending |
| RCMTRcm Technologies, Inc. | $291.83M | 17.8× | $319.4M | +14.7% | $16.33M | $6.59M | $5.84M | AI pending |
| FULCFulcrum Therapeutics, Inc. | $291.84M | — | $0 | -100.0% | -$74.88M | $48.47M | $5.28M | AI pending |
| MTNECH4 Natural Solutions Corp | $292.68M | — | — | — | — | $0 | — | AI pending |
| FATEFate Therapeutics Inc | $292.96M | — | $6.65M | -51.2% | -$136.32M | $32.43M | $75.68M | AI pending |
| BACCBlue Acquisition Corp | $293.04M | 66.6× | — | — | — | $201.86K | — | AI pending |
| NHICNewHold Investment Corp. III | $293.25M | — | — | — | — | $364K | — | AI pending |
| OVLYOak Valley Bancorp | $293.44M | 12.4× | $81.73M | +6.7% | $23.91M | $194.8M | $7.62M | AI pending |
| PACHPioneer Acquisition I Corp | $293.5M | 36.9× | — | — | — | $468.67K | — | AI pending |
| IRHOIron Horse Acquisition II Corp. | $294.67M | 115.9× | — | — | — | $46.83K | — | AI pending |
| HCACHall Chadwick Acquisition Corp | $294.89M | — | — | — | — | $30.22K | — | AI pending |
| SVAQSilicon Valley Acquisition Corp. | $294.97M | 119.8× | — | — | — | $1.18M | — | AI pending |
| KWYKINGSWAY Corp | $295.67M | — | $135M | +23.4% | -$10.25M | $7.37M | $51.35M | AI pending |
| GPACGeneral Purpose Acquisition Corp. | $295.86M | 80.5× | — | — | — | $937.89K | — | AI pending |
| BCYCBicycle Therapeutics PLC | $296.01M | — | $72.59M | +105.8% | -$218.96M | $510.05M | $15.21M | AI pending |
| NNBRNn Inc | $296.05M | — | $422.21M | -9.1% | -$34M | $16.45M | $214.8M | AI pending |